118464-69-0

Upstream product

• 75-05-8 acetonitrile 

Downstream Products

• 807342-24-1 (+)-(3R,4S)-[[4-(4-chlorophenyl)-1-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)methylsulfanyl]methyl]piperidine 
• 755029-81-3 N-({3-[3-(3-methoxy-4-nitrophenyI)-11-oxo-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-8-yl]propanoyl}oxy)ethanimidamide 
• 871343-71-4 C₁₅H₁₄Cl₂N₄OS 
• 335259-25-1 8-(4-Fluoro-phenyl)-4-[3-(3-methyl-[1,2,4]oxadiazol-5-yl)-phenyl]-1,3-dihydro-benzo[b][1,4]diazepin-2-one 
• 157695-16-4 3-methyl-5-(4-iodophenyl)-1,2,4-oxadiazole 
• 881028-34-8 [5-(3-methyl-[1,2,4]oxadiazol-5-yl)-4-phenyl-thiazol-2-yl]-carbamic acid tert-butyl ester 
• 910777-89-8 N-([(8-([(2-ethyl-6-methylphenyl)methyl]amino)-2,3-dimethylimidazo[1,2-a]pyridin-6-yl)carbonyl]oxy)ethanimidamide 
• 937079-53-3 3-{2-[3-(4-fluorophenyl)-isoxazol-5-yl]-2-[(E)-propoxyimino]-ethoxy}-5-(3-methyl-[1,2,4]oxadiazol-5-yl)-benzoic acid methyl ester 
• 1172639-56-3 [3-Methoxy-4-(3-methyl-[1,2,4]oxadiazol-5-yl)-phenyl]-(4-phenyl-4,5,6,7-tetrahydro-benzothiazol-2-yl)-amine 
• 865706-92-9 3-methyl-5-phenylsulfanylmethyl-[1,2,4]oxadiazole 
• 874452-27-4 N-((4-methoxycarbonylbenzoyl)oxy)acetamidine 
• 1092113-94-4 (S)-5-[3-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-9-methylthio-1,2,3,3a,4,5-hexahydro-5,8,10,10b-tetraazabenzo[e]azulen-6-one 
• 1236796-02-3 2-((1r,4r)-4-(4-(4-amino-2-methoxy-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-6(5H)-yl)phenyl)cyclohexyl)-N-((Z)-1-(hydroxyimino)ethyl)acetamide 
• 1236795-99-5 (E)-2-(4-(4-amino-2-methoxy-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-6(5H)-yl)phenyl)-N-(1-(hydroxyimino)ethyl)-2-methylpropanamide 

Relevant academic research and scientific papers

Synthesis of various 3-substituted 1,2,4-oxadiazole-containing chiral β3- and α-amino acids from Fmoc-protected aspartic acid

Various 3-substituted chiral 1,2,4-oxadiazole-containing Fmoc-β 3- and α-amino acids were synthesized from FmoC-(L or D)-Asp(OtBu)-OH and Fmoc-L-Asp-OtBu, respectively, in three steps (i.e., condensation of an aspartyl derivative with different

Synthesis of 3,5-disubstituted-1,2,4-oxadiazoles using tetrabutylammonium fluoride as a mild and efficient catalyst

Tetrabutylammonium fluoride (TBAF) was found to be a mild and efficient catalyst for the synthesis of 3,5-disubstituted-1,2,4-oxadiazoles. Using 0.1 - 1.0 equivalents of TBAF in THF for 1 - 24 h at room temperature, alkanoyl- and aroyloxyamidines were converted in high yield to the corresponding 3,5-disubstituted-1,2,4-oxadiazoles. A variety of R and R′ substituents were investigated.